Nyenta.com

Menu
  • Home
  • Business
  • Technology
  • Financial
  • Education
  • Health
  • Entertainment
  • Arts
  • Books
Menu

LifeNome Launches Precision Longevity OS
Nyenta.com/10310808

Trending...
  • Multi-Billion Dollar Drone Cleaning Market Addressed via New UAE Office, AI Drone and Quantum Computing Solutions in Varied Industries ZenaTech, Inc
  • Spac Recovery Co. Files $590 Million Lawsuit Against Blackstone Products, Nomura , Franklin Square, Oaktree et al
  • AUACOM Signs a Statement of Shared Interest with BMCC
The NYC-based precision health company unveils the world's first B2B(2C) plug and play marketplace for consumer health enterprise rapid go to market.

NEW YORK - Nyenta -- LifeNome, a global leader in precision health and systems biology, today announced the official launch of its groundbreaking Precision Longevity OS, the world's first end-to-end operating system for B2B(2C) personalized healthspan and lifespan optimization.

Built on over 1,000 API endpoints and 53 industry solutions, the Longevity OS enables enterprises to offer scientifically validated, hyper-personalized longevity journeys — powered by multi-omics insights, AI-driven analytics, clinical biomarker integration, and telehealth intervention networks.

"We're entering a new era where health isn't just about treating disease, it's about proactively optimizing longevity," said Ali Mostashari, PhD, CEO of LifeNome. "The Precision Longevity OS gives companies across insurance, digital health, pharma, and wellness the tools they need to lead in this new longevity economy."

More on Nyenta.com
  • Danielle Brown Becomes 2x New York Times Bestselling Author With Her Second Cookbook, Life-Changing Salads, as Launch Party Draws Hundreds and Media Tour Reaches Millions
  • Best Selling Author, Apostle Tonya Releases a Commentary on the Epistles to the Thessalonians
  • NBA Legend Jeremy Lin, Benny Luo and Sy Huq Team Up to Executive Produce Powerful New Short Film "Ayo, Check Up!"
  • Wise Business Plans® Expands National Reach as Go-To Resource for Custom Business Plans
  • Destroy All Toys Inc. Returns to Kaiju Brooklyn 2025 as Premier Kaiju Toy Convention Vendor

Key Features and Marketplace Overview
  • Multi-Omics Data Integration: DNA, microbiome, methylation, and blood biomarkers.
  • Clinical-Grade Capabilities: CLIA/CAP-certified lab testing and certified telehealth providers trained in cardiovascular, metabolic, and chronic disease management.
  • Plug-and-Play Deployment: 1,000+ API endpoints, white-label apps, and fully modular components.
  • Dynamic Health Optimization: Predictive risk scoring, personalized interventions, continuous health trajectory modeling.
  • Marketplace Ecosystem: Solutions for healthspan extension, chronic disease prevention, women's health, mental well-being, fitness, and weight management.

The Longevity OS marketplace empowers partners to rapidly build and scale branded longevity solutions, creating new revenue streams, enhancing customer engagement, and delivering superior health outcomes. The average partner saves 38% in go to market cost and 55% in go to market time for MVPs.

Value Proposition for Clients
  • Accelerate Time-to-Market with ready-to-deploy precision health and longevity capabilities.
  • Enhance Differentiation through scientifically validated, deeply personalized experiences.
  • Drive Higher Retention and LTV by engaging users in ongoing health optimization journeys.
  • Unlock New Premium Offerings in the exploding $27 trillion global longevity economy.

About LifeNome

More on Nyenta.com
  • The 4th Annual Rockaway Dog Parade Returns!
  • Skyline Introduces the Industry's First High-Quality Portable Counter with LED Edge Lighting
  • Comparison of ListKit with competitors on the B2B lead generation market
  • Choosing a Cooking Oil Supplier: Key Factors to Consider
  • Men's Health Network Urges Memphis Community to Attend 2025 Men's Health Month Summit

https://www.lifenome.com

Founded in 2016, by top cited scholars in complexity science, computational genomics, and semantic AI, LifeNome is a precision health company pioneering the integration of multi-omics, AI, and systems biology to transform personalized health and longevity. With clients and partners across North America, Asia, and the Middle East, Lifenome has served over 600,000 end users in more than 14 countries globally. CB Insights has named Lifenome an "Outperformer" in a matchup with 15 top precision health companies including Viome, Inside Trackers, Foodsmart and others.

Contact
Press Team
Lifenome Inc.
www.lifenome.com
***@lifenome.com


Source: Lifenome Inc

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Nyenta.com
  • City of New Rochelle Celebrates Ribbon-Cutting of Inaugural Downtown Recreation Center
  • New Rochelle: NRPD Memorial and Awards Ceremony
  • Koplon Implant & Family Dentistry Receives National Recognition as One of the Best Dental Implant Practices in the U.S
  • San Antonio Buyer Secures 2.375% Mortgage in 2025-Broker Reveals the Mistake Costing Buyers Thousands
  • New Rochelle: NRPD Dedicates Marine 2 Patrol Boat in Honor of P.O. Kathleen O'Connor-Funigiello
  • Heritage at South Brunswick Grand Opening Success!
  • NASA, International Astronauts Address Students from New York, Ohio
  • New Book Cuts Through the Hype, Explains Why Stablecoins Matter Right Now
  • WST INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In WST To Contact Him Directly To Discuss Their Options
  • Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
  • $1B Target by 2027 Amid eSIM, Global Roaming Expansion; $57.6M Q1 Revenue and Market Uplisting, Advancing Toward IQSTEL, Inc. (Stock Symbol: IQST)
  • LIB TH-50/TH-80 Benchtop Environmental Chamber Drives Global Demand
  • Marc Soucy's Newest Music Series Approaches Its One Year Mark
  • Rising R&B Star Nyasia Chane'l Officially Releases Empowering Afrobeat-Infused Anthem "Numb" on All Platforms
  • Smart, Foldable Walking Treadmill by WELLFIT – Just $129
  • Fairmint Releases Whitepaper for Open Captable Protocol (OCP) to Advance On-Chain Equity Securities
  • Vistra to Acquire Natural Gas Assets, Building on Industry-Leading Generation Portfolio to Better Serve Customers
  • Conversation with Emily Feiner on Free Speech and Political Dissent
  • Rochester: International Plaza to Host "Malcolm X Celebration and Artistic Showcase" on Sunday, May 18
  • Breaking Barriers: Gotham Lab Unpacks the Biggest Challenges in Global Film Localization

Popular on Nyenta

  • Multimedia Artist Cynthia Pinot Returns to Rochester Contemporary Art Center's 6x6 Show -May 9,2025 - 211
  • Inked Originals: $25K, a Tattoo by Bang Bang, and Inked Magazine Fame - 181
  • Axiros Confirms Continued Compliance with ISO/IEC 27001:2022 After Surveillance Audit - 120
  • New Rochelle: TagNR Community Tag Sale- RESCHEDULED TO MAY 10 - 116
  • New Rochelle: Free Compost to Westchester County Residents throughout May - 107
  • City of New Rochelle to Host Sustainability Community Events During Earth Week and Beyond - 107
  • SSATI Completes Acquisition of Invex Technology Solutions and ITIC Corporation's Government Support Services - 102
  • City of New Rochelle to Host Jewish-American Heritage Month Event
  • New Rochelle Police Department Arrests Suspect in Slashing Incident at 117 Guion Place
  • New Rochelle Police Department Responds to Armed Robbery at 130 Pelham Road

Similar on Nyenta

  • Sumis Partners Launches, Uniting Industry Leaders to Redefine Life Sciences Consulting
  • Koplon Implant & Family Dentistry Receives National Recognition as One of the Best Dental Implant Practices in the U.S
  • $7.8M Financing Boosts NRx's Expansion with Kadima Institute Acquisition for PTSD and Depression Care: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
  • Plan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression
  • $34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thinner, Less Problematic Than Warfrain: $CVKD
  • Manhattan BioSolutions' TxD Payload Collaboration Secures REACH Award for ADC Development
  • 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
  • $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
  • Meditech International Inc. and Los Angeles Rams Continue Strategic Partnership to Enhance Athlete Performance and Recovery
  • Mission 3A Establishes Healthcare Advisory Board with Addition of Industry Leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet
Copyright © 2025 nyenta.com | Terms of Service | Privacy Policy | Contribute | Contact Us